Drugs / pp65/tumor mRNA RNA-LP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07560709 | — | osteosarcoma | University of Florida | No longer available | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | pp65/tumor mRNA RNA-LP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07560709 ↗ |
| Modality | Vaccine | “DOTAP liposome vaccine” NCT07560709 ↗ |
| Route | Intravenous | “administered intravenously” NCT07560709 ↗ |